1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijlbpr@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers. So only full paper submission should be [Read More]

HCV Infection and its Association with HLA Alleles

A Shankarkumar and U Shankarkumar
National Institute of Immunohaemtology, 13 Floor, KEM Hospital. Parel, Mumbai - 400012, Maharashtra, India.
Abstract—Host genetic diversity is believed to contribute to the spectrum of clinical outcomes in hepatitis C virus (HCV) infection. The frequencies of HLA class I and class II alleles of HCV infected were reviewed and analyzed with literature available from published literature. The analysis showed that he associations of HLA-A*02 and HLA-DRB1*12 with HCV infection are opposite with different races. HLA-A*03, Cw*05, DRB1*01, DQB1*03 and DQB1*05 are associated with viral clearance while HLA-DRB1*07 and DQB1*02 are risk markers for viral persistence of HCV infection in Midwestern Americans. These results reveal ethnically and geographically different distribution of HLA-genes which are associated with the outcome of HCV infection.

Index Terms—HCV, HLA, association

Cite: A Shankarkumar and U Shankarkumar, "HCV Infection and its Association with HLA Alleles," International Journal of Life Sciences Biotechnology and Pharma Research, Vol. 1, No. 2, pp. 10-19, April 2012.
Copyright © 2012-2015 International Journal of Life Sciences Biotechnology and Pharma Research, All Rights Reserved